POZEN Logo
Print Page   Close Window

Press Release

POZEN to Present at Bear Stearns 17th Annual Healthcare Conference

CHAPEL HILL, N.C.--(BUSINESS WIRE)--Sept. 8, 2004--POZEN Inc. (NASDAQ: POZN) announced today that the Company will be speaking to investors at the Bear Stearns 17th Annual HealthCare Conference on Tuesday, September 14, at 4:15 p.m. Eastern Time in New York. The company presentation will be webcast live and archived on POZEN's home page at www.pozen.com.

POZEN is a pharmaceutical company committed to developing therapeutic advancements for diseases with unmet medical needs where it can improve efficacy, safety, and/or patient convenience. Since its inception, POZEN has focused its efforts primarily on the development of pharmaceutical products for the treatment of migraine. POZEN has development and commercial alliances with GlaxoSmithKline, Xcel Pharmaceuticals, and Nycomed. The company's common stock is traded on The Nasdaq Stock Market under the symbol "POZN". For detailed company information, including copies of this and other press releases, see POZEN's website: www.pozen.com.

CONTACT: POZEN Inc.
Bill Hodges, Chief Financial Officer, 919-913-1030
John Barnhardt, Vice President, Finance and
Administration, 919-913-1030

SOURCE: Pozen Inc.